Amy is both a litigator and an experienced client counselor. For nearly two decades, she has defended businesses in multidistrict litigation, class actions and other complex cases.

Amy has successfully managed and efficiently resolved large disputes involving a variety of theories including complex commercial, product liability, consumer fraud, concussion, medical monitoring and toxic tort. She has a broad base of experience with both domestic and international companies in a host of industries such as health care IT, tobacco, alcohol beverages, manufacturing, resource mining, pharmaceutical, and collegiate sports associations. Amy has litigated in state and federal courts as well as in arbitration and other alternative venues.

Representative matters include the following:

  • Health care software product liability litigation: A relatively new theory, Amy has had great success resolving a series of recent filings, including a $50 million dollar case won on summary judgment.  

  • Health care software commercial litigation and alternative dispute resolution: Amy has successfully resolved multiple business-to-business disputes involving multimillion dollar software contracts. In one case, with her client under threat of litigation, Amy negotiated a settlement in which the threatening party paid her client several million dollars and never filed suit.

  • In re Taxotere (Docetaxel) Products Liability Litigation MDL (E.D. La.): Amy leads a team of lawyers that has won multiple case-dispositive motions in this large MDL.  
  • In re Motor Fuel Temperature MDL (D. Kan.): Amy managed more than 30 consumer fraud and class action cases through a bellwether trial, which resulted in a unanimous defense verdict. Amy’s efforts won her recognition as a Missouri Lawyers Weekly “Legal Champion,” and the team received the “Value Champion” award presented by the Association of Corporate Counsel.
  • Oklahoma lead mining litigation (N.D. Okla.): Amy helped successfully resolve natural resource and property damage claims brought by tribal authorities as well as thousands of matters brought by individual home owners claiming property damage and seeking medical monitoring.
  • International tobacco litigation and counseling: For three years, Amy litigated from Shook’s Geneva office advising Philip Morris International on a variety of litigation matters and related business issues. Amy coordinated the defense of numerous product liability and consumer fraud matters (both class actions and individual matters) throughout Europe and the Middle East, mainly in Finland, Israel and Italy. She was primarily responsible for the defense and efficient management of more than 2,000 product liability actions filed in Italy, all of which were favorably resolved.

In addition to being a litigator, Amy has counseled both multinational and U.S. clients on many different litigation-avoidance and mitigation strategies including (1) customer statements related to potential product issues and associated risks, (2) U.S. and foreign labeling regulations; (3) considerations related to new-ingredient usage; (4) product development best practices; (5) website statements and associated risks; and (6) sales and marketing best practices.

Amy’s broad base of experiences makes her uniquely positioned to advise businesses not just on litigation matters, but also on avoidance and mitigation through relevant, business-based best practices. Her multifaceted approach provides value not just in the courtroom or at the negotiating table but to the business as a whole.


Amy M. Crouch & Kerensa Cassis, How Courts Apply Contact-Sports Exception To Nonplayers, Law360, June 11, 2018.

William A. Yoder, Amy M. Crouch & Melissa M. Plunkett, The Starting Point for Effective Rule 30(b)(6) Depositions, For the Defense, July 2014, at 48. 

Timothy E. Congrove, Amy M. Crouch & Ina D. Chang, How Plaintiffs' Class Counsel Try to Make Differences Vanish, For the Defense, Oct. 2008, at 27. 

Media Coverage

Sanofi May Assert Lack of Knowledge of Taxotere Hair Loss Risk, Bloomberg Law, July 2, 2020.